ITV Tyne Tees and Granada Reports recently featured the journey of two-year-old Teddi Shaw, who became the first child in the UK to receive NHS life-saving gene therapy treatment, Libmeldy® at MFT.
Read more
R&I colleagues welcomed James McLaughlin, Chief Executive for Cure Leukaemia, to MFT, as he ran 14 km across Manchester to raise funds for blood cancer research at Manchester Royal Infirmary (MRI).
Read more
Good Morning Britain and ITV Granada Reports featured MFT’s BCAN-RAY (Breast Cancer Risk Assessment in Young Women) study, which is running from The Nightingale Centre at Wythenshawe Hospital.
Read more
A 79-year-old woman is the first global participant to a research study that could help some of the millions of people worldwide living with glaucoma – a leading cause of irreversible blindness.
Read more
Bruntwood SciTech, commenced construction on a £42m, 125,000 sq ft specialist lab and office workspace at the Citylabs cluster to strengthen the internationally significant health innovation campus.
Read more
A special event took place to celebrate 10 years of MFT’s involvement in ‘Enroll-HD’ – a global registry study for Huntington's disease.
Read more
A revolutionary ward-based genetic test which can prevent stroke related death has received a UKCA product mark, paving the way for its introduction to the NHS.
Read more
For a nine-year old boy and his family, being part of Duchenne Muscular Dystrophy clinical research at NIHR Manchester CRF at Royal Manchester Children's Hospital has been ‘amazing,’ for many reasons.
Read more
